Heartbeat Health Raises $8.2M Series A to Expand Delivery of Best-in-Class Virtual Cardiovascular Care

NEXT STORY
Generex Subsidiary NuGenerex Immuno-Oncology (Formerly Antigen Express) Files Form 10 Registration Statement with the Securities and Exchange Commission
PREV STORY
Oxurion NV Business Update – FY 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G1 Therapeutics Announces Addition of Alicia Secor to Board of Directors

author_avatar
NASDAQ Market News

Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment at the 2018 European Society for Medical Oncology (ESMO) Congress

- Key findings presented in poster discussion demonstrate clear abscopal effect of intratumoral tilsotolimod ...

author_avatar
NASDAQ Market News

Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on June 9, 2020

author_avatar
NASDAQ Market News